Trial intelligence / Profile preview

IV Lornoxicam for Postoperative Pain Following Bunionectomy

NCT00293631Phase 2Completed

Sponsor
Pozen
Start
Nov 2005
Primary completion
Mar 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of lornoxicam in postoperative pain (4 arms), sponsored by Pozen. Primary endpoints: Total Pain Relief and Safety and Tolerability. Started Nov 2005; status: completed.

02

Drugs

lornoxicam
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT00293631.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00293631.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call